The European Association for the Study of the Liver (EASL) calls on the EU to accelerate public health policies to reduce the high human and financial burden of liver diseases
With this statement, EASL reiterates evidence-based recommendations to the European Union Institutions for the next political term, to address boldly the human and financial burden of liver disease in Europe. We can no longer ignore the enormous impact on millions of lives across Europe, and on health budgets in every country.